Key statistics
As of last trade, Pulse Biosciences Inc (PLSE:NAQ) traded at 18.10, 44.11% above the 52 week low of 12.56 set on Nov 20, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 18.94 |
|---|---|
| High | 18.94 |
| Low | 18.10 |
| Bid | 18.08 |
| Offer | 18.21 |
| Previous close | 18.73 |
| Average volume | 461.48k |
|---|---|
| Shares outstanding | 67.99m |
| Free float | 17.88m |
| P/E (TTM) | -- |
| Market cap | 1.27bn USD |
| EPS (TTM) | -1.08 USD |
Data delayed at least 15 minutes, as of Mar 02 2026 15:50 GMT.
More ▼
- Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Pulse Biosciences to Present at the 46th Annual TD Cowen Healthcare Conference
- Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2025 Financial Results
- Pulse Biosciences Presents Late-Breaking Data from nPulse™ Cardiac Catheter System First-In-Human Feasibility Study at the AF Symposium
- Pulse Biosciences Schedules Fourth Quarter & Full Year 2025 Financial Results Conference Call for February 19, 2026
- Pulse Biosciences’ nPulse™ Cardiac Catheter to Be Featured in Multiple Presentations at the AF Symposium
- Pulse Biosciences, Inc. Appoints Maria Sainz to its Board of Directors
- Pulse Biosciences Selected to Present Late-Breaking Data from the nPulse Cardiac Catheter Study at the AF Symposium
- Pulse Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
- Pulse Biosciences Announces FDA IDE Approval to Initiate its nPulse Cardiac Catheter Ablation System Study for the Treatment of Atrial Fibrillation
More ▼
